抽象的な
Eosinopenia as a Diagnostic Marker in Covid-19?
Francis Ajeneye, Oladimeji Olofin
Eosinopenia is defined as a decrease of circulating eosinophils<0.01 × 109/l. Eosinopenia is mediated by adrenalglucocorticosteroids and epinephrine in acute stress, whereas inacute inflammatory states, this is not reliant upon the endocrinemechanisms. The use of eosinopenia as a marker is aencouraging observation in COVID-19 infection, besidesrequire further investigation
免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。